Axonics Modulation Technologies Stock Price To Earnings To Growth
| AXNXDelisted Stock | USD 70.98 0.48 0.68% |
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Price To Earnings To Growth Analysis
Axonics Modulation's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Axonics Modulation Price To Earnings To Growth | (0.56) X |
Most of Axonics Modulation's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Axonics Modulation Technologies has a Price To Earnings To Growth of -0.56 times. This is 178.87% lower than that of the Health Care Equipment & Supplies sector and 129.47% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 111.45% higher than that of the company.
Axonics Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in price to earnings to growth category among its peers.
Axonics Fundamentals
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 3.32 B | ||||
| Shares Outstanding | 51.11 M | ||||
| Shares Owned By Insiders | 1.26 % | ||||
| Shares Owned By Institutions | 87.22 % | ||||
| Number Of Shares Shorted | 3.31 M | ||||
| Price To Earning | (10.68) X | ||||
| Price To Book | 5.46 X | ||||
| Price To Sales | 8.40 X | ||||
| Revenue | 366.38 M | ||||
| Gross Profit | 197.66 M | ||||
| EBITDA | 7.78 M | ||||
| Net Income | (6.09 M) | ||||
| Cash And Equivalents | 213.23 M | ||||
| Cash Per Share | 4.53 X | ||||
| Total Debt | 27.62 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 10.49 X | ||||
| Book Value Per Share | 13.00 X | ||||
| Cash Flow From Operations | (2.02 M) | ||||
| Short Ratio | 7.14 X | ||||
| Earnings Per Share | (0.10) X | ||||
| Price To Earnings To Growth | (0.56) X | ||||
| Target Price | 72.0 | ||||
| Number Of Employees | 797 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 3.63 B | ||||
| Total Asset | 719.92 M | ||||
| Retained Earnings | (380.35 M) | ||||
| Working Capital | 445.61 M | ||||
| Current Asset | 171.14 M | ||||
| Current Liabilities | 12.98 M | ||||
| Net Asset | 719.92 M |
About Axonics Modulation Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axonics Modulation Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axonics Modulation using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axonics Modulation Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |